Goldshtein D, Shad Y, McWhirter E, Tozer R, et al. Meaningful efficacy measures and trial endpoints in patients with advanced melanoma being considered for adjuvant systemic therapy: a prospective patient survey study. Melanoma Res 2026 Jun 10. doi: 10.1097/CMR.0000000000001114.
PMID: 42268264